InvestorsHub Logo
Followers 163
Posts 12871
Boards Moderated 1
Alias Born 01/26/2016

Re: Rkmatters post# 54257

Wednesday, 02/17/2016 3:21:28 PM

Wednesday, February 17, 2016 3:21:28 PM

Post# of 698671
Rkmatters,

TMZ was approved based on a 2 month demonstrated OS benefit. No more benefit than this will be ascribed to it with regard to this DCVax trial since no other blinded trial proves there is more. SOC encorporates this benefit which is why any additional benefit is ascribed to L. This is why any synergy is low hanging fruit just waiting to be picked. DCVax is positioned very well to take advantage of a possible synergistic advantage in the measurement of OS and this is the reason why you decided to test the waters again right?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News